This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Tung-Ping Su, MD; Michael Pagliaro, RN; Peter J. Schmidt, MD; David Pickar, MD; Owen Wolkowitz, MD; David R. Rubinow, MD

JAMA. 1993;269(21):2760-2764.

Abstract
Objective.
—To evaluate the acute effects of anabolic steroids on mood and behavior in male normal volunteers.

Design.
—A 2-week, double-blind (subject and rater), fixed-order, placebo-controlled crossover trial of methyltestosterone.

Setting.
—An inpatient research unit at the National Institutes of Health.

Subjects.
—A volunteer sample of 20 men who were medication free, free of medical and psychiatric illness, not involved in athletic training, and had no prior history of anabolic steroid use.

Intervention.
—A sequential trial for 3 days each of the following four drug conditions: placebo baseline, low-dose methyltestosterone (40 mg/d), high-dose methyltestosterone (240 mg/d), and placebo withdrawal.

Main Outcome Measures.
—Mood and behavioral ratings were completed during each drug condition and included both subjective and objective measures.

Results.
—Significant (P<.05) albeit subtle increases in symptom scores were observed during high-dose methyltestosterone administration compared with baseline in positive mood (euphoria, energy, and sexual arousal), negative mood (irritability, mood swings, violent feelings, and hostility), and cognitive impairment (distractibility, forgetfulness, and confusion). An acute manic episode was observed in one of the 20 subjects, representing a 5% incidence, even under these conservative conditions. An additional subject became hypomanic. Baseline characteristics including family psychiatric history or previous drug abuse did not predict symptom changes.

Conclusion.
—This is the first placebo-controlled prospective study demonstrating the adverse and activating mood and behavioral effects of anabolic steroids.

(JAMA. 1993;269:2760-2764)

Author Affiliations
From the Section on Behavioral Endocrinology, Biological Psychiatry Branch (Drs Su, Schmidt, and Rubinow), and Experimental Therapeutics Branch (Drs Su, Pickar, and Wolkowitz), National Institute of Mental Health, Bethesda, Md; Mental Health Nursing Service, Nursing Department, Clinical Center, National Institutes of Health, Bethesda, Md (Mr Pagliaro); and Department of Psychiatry, University of California, San Francisco (Dr Wolkowitz).

Footnotes
Reprint requests to Section on Behavioral Endocrinology, National Institute of Mental Health/NIH, 9000 Rockville Pike, Bldg 10, Room 3N238, Bethesda, MD 20892 (Dr Su).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?
Ebinger et al.
J Psychopharmacol 2009;23:841-853.
ABSTRACT  

Anabolic androgenic steroids: what the psychiatrist needs to know
Rashid et al.
Adv. Psychiatr. Treat. 2007;13:203-211.
ABSTRACT | FULL TEXT  

Criminality Among Individuals Testing Positive for the Presence of Anabolic Androgenic Steroids.
Klotz et al.
Arch Gen Psychiatry 2006;63:1274-1279.
ABSTRACT | FULL TEXT  

The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
Handelsman
J. Clin. Endocrinol. Metab. 2006;91:1646-1653.
ABSTRACT | FULL TEXT  

Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
Bloch et al.
Arch Gen Psychiatry 2006;63:450-456.
ABSTRACT | FULL TEXT  

Psychiatric Complications of Anabolic Steroid Abuse
Hall et al.
Psychosomatics 2005;46:285-290.
ABSTRACT | FULL TEXT  

The Effects of Pharmacologically Induced Hypogonadism on Mood in Healthy Men
Schmidt et al.
Arch Gen Psychiatry 2004;61:997-1004.
ABSTRACT | FULL TEXT  

Effects of Testosterone on Mood, Aggression, and Sexual Behavior in Young Men: A Double-Blind, Placebo-Controlled, Cross-Over Study
O'Connor et al.
J. Clin. Endocrinol. Metab. 2004;89:2837-2845.
ABSTRACT | FULL TEXT  

Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents
Nilsson et al.
HEALTH PROMOT INT 2004;19:61-67.
ABSTRACT | FULL TEXT  

Current Concepts in Anabolic-Androgenic Steroids
Evans
Am J Sports Med 2004;32:534-542.
ABSTRACT | FULL TEXT  

Medical aspects of drug use in the gym
DTB 2004;42:1-5.
ABSTRACT | FULL TEXT  

OESTRADIOL AND HUMAN MALE ALCOHOL-RELATED AGGRESSION
Eriksson et al.
Alcohol Alcohol 2003;38:589-596.
ABSTRACT | FULL TEXT  

Anabolic Steroids
Kuhn
Recent Prog Horm Res 2002;57:411-434.
ABSTRACT | FULL TEXT  

Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
Basaria et al.
J. Clin. Endocrinol. Metab. 2001;86:5108-5117.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary Findings
Daly et al.
Arch Gen Psychiatry 2001;58:172-177.
ABSTRACT | FULL TEXT  

Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men: A Randomized Controlled Trial
Pope et al.
Arch Gen Psychiatry 2000;57:133-140.
ABSTRACT | FULL TEXT  

Testosterone in Psychiatry: Risks and Benefits
Yates
Arch Gen Psychiatry 2000;57:155-156.
FULL TEXT  

Endogenous Sex Hormones and Cognitive Function in Older Men
Barrett-Connor et al.
J. Clin. Endocrinol. Metab. 1999;84:3681-3685.
ABSTRACT | FULL TEXT  

Review : Gonadal Steroids and Affective Illness
Roca et al.
Neuroscientist 1999;5:227-237.
ABSTRACT  

Abuse liability of testosterone
Fingerhood et al.
J Psychopharmacol 1997;11:59-63.
ABSTRACT  

Androgens in Men -- Uses and Abuses
Bagatell and Bremner
NEJM 1996;334:707-715.
FULL TEXT  

Sentinel Effect of Drug Testing for Anabolic Steroid Abuse
Fuentes et al.
J Law Med Ethics 1994;22:224-230.
 

Addiction Medicine
Franklin
JAMA 1994;271:1650-1651.
ABSTRACT  

Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use: A Controlled Study of 160 Athletes
Pope and Katz
Arch Gen Psychiatry 1994;51:375-382.
ABSTRACT  

Anabolic-Androgenic Steroid Use in the United States
Yesalis et al.
JAMA 1993;270:1217-1221.
ABSTRACT  

NEUROPSYCHIATRIC EFFECTS OF ANABOLIC STEROIDS
JWatch General 1993;1993:5-5.
FULL TEXT